AFLURIA TETRA

SEQIRUS PTY LTD🇨🇦 Health Canada

Approval Id: af11603ecdc0905f
Drug Approval Canada Name: AFLURIA TETRA
Product Name: AFLURIA TETRA
Status: Marketed
Status Date: 2020-09-23
Original Market Date: 2020-09-23
Din: 02473313
Drug Class: Human
Dosage Form: Suspension
Route Of Administration: Intramuscular
Schedule: Schedule D
Ahfs: 80:12.00
Atc Original: J07BB02 INFLUENZA, INACTIVATED, SPLIT VIRUS OR SURFACE ANTIGEN
Atc Name: j 07 bb 02
Aig Number: 0455410003
Company Name: SEQIRUS PTY LTD
Company Address: 63 Poplar Road, Parkville, Victoria, Australia, 3052
Company Detail Path: /organization/seqirus-pty-ltd

HAEMAGGLUTININ-STRAIN A (H1N1)

15 MCG / 0.5 ML

HAEMAGGLUTININ-STRAIN A (H3N2)

15 MCG / 0.5 ML

HAEMAGGLUTININ-STRAIN B (VICTORIA)

15 MCG / 0.5 ML

HAEMAGGLUTININ-STRAIN B (YAMAGATA)

15 MCG / 0.5 ML

Authorized

Agency

Health Canada

Country

🇨🇦

Approval Date

Jul 4, 2025

Approval ID

af11603ecdc0905f

Type

Standard